CH460020A - Verfahren zur Herstellung von Piperazinderivaten - Google Patents

Verfahren zur Herstellung von Piperazinderivaten

Info

Publication number
CH460020A
CH460020A CH1059465A CH1059465A CH460020A CH 460020 A CH460020 A CH 460020A CH 1059465 A CH1059465 A CH 1059465A CH 1059465 A CH1059465 A CH 1059465A CH 460020 A CH460020 A CH 460020A
Authority
CH
Switzerland
Prior art keywords
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
CH1059465A
Other languages
English (en)
Inventor
Irikura Tsutomu
Masuzawa Kuniyasui
Nishino Keigo
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of CH460020A publication Critical patent/CH460020A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1059465A 1964-07-31 1965-07-28 Verfahren zur Herstellung von Piperazinderivaten CH460020A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4370264 1964-07-31

Publications (1)

Publication Number Publication Date
CH460020A true CH460020A (de) 1968-07-31

Family

ID=12671133

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1059465A CH460020A (de) 1964-07-31 1965-07-28 Verfahren zur Herstellung von Piperazinderivaten

Country Status (6)

Country Link
US (1) US3288795A (de)
BE (1) BE666989A (de)
CH (1) CH460020A (de)
DE (1) DE1570037A1 (de)
FR (1) FR5036M (de)
GB (1) GB1051527A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051504A (en) * 1989-05-31 1991-09-24 Basf Aktiengesellschaft Doubled triphenylmethane dyes having bis acylpiperazine linkage

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502679C3 (de) * 1975-01-23 1981-07-23 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel
US5292726A (en) * 1991-05-22 1994-03-08 Merck & Co., Inc. N,N-diacylpiperazines
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5348955A (en) * 1993-06-22 1994-09-20 Merck & Co., Inc. N,N-diacylpiperazines
US20040266784A1 (en) * 1998-06-30 2004-12-30 Snutch Terrance P. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
US6492375B2 (en) 1998-06-30 2002-12-10 Neuromed Technologies, Inc. Partially saturated calcium channel blockers
US6943168B2 (en) * 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6951862B2 (en) * 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US7186726B2 (en) * 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
US20060084660A1 (en) * 1998-06-30 2006-04-20 Neuromed Technologies Inc. Calcium channel blockers comprising two benzhydril moieties
US6387897B1 (en) 1998-06-30 2002-05-14 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
US20050227999A1 (en) * 2004-04-09 2005-10-13 Neuromed Technologies Inc. Diarylamine derivatives as calcium channel blockers
EP2019676A2 (de) * 2006-05-11 2009-02-04 Neuromed Pharmaceuticals, Ltd. Verfahren zur erhöhung der bioverfügbarkeit von benzhydrylpiperazinhaltigen verbindungen
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
WO2012122279A1 (en) 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051504A (en) * 1989-05-31 1991-09-24 Basf Aktiengesellschaft Doubled triphenylmethane dyes having bis acylpiperazine linkage

Also Published As

Publication number Publication date
BE666989A (de) 1965-11-16
FR5036M (de) 1967-05-02
US3288795A (en) 1966-11-29
DE1570037A1 (de) 1970-02-05
GB1051527A (de)

Similar Documents

Publication Publication Date Title
CH467784A (de) Verfahren zur Herstellung von Pyrimidinderivaten
CH501647A (de) Verfahren zur Herstellung von Piperazinderivaten
CH471780A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH460020A (de) Verfahren zur Herstellung von Piperazinderivaten
CH494207A (de) Verfahren zur Herstellung von Benzothiazepin-Derivaten
CH451153A (de) Verfahren zur Herstellung von 3-Hydroxyisoxazolderivaten
CH475979A (de) Verfahren zur Herstellung von Aziridin-Derivaten
CH461461A (de) Verfahren zur Herstellung von Derivaten des N-Acylvinylamins
CH460783A (de) Verfahren zur Herstellung von Derivaten des 3-Phenylpyrrols
CH479610A (de) Verfahren zur Herstellung von Dibenzothiazinderivaten
CH457452A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH458362A (de) Verfahren zur Herstellung von Piperazinderivaten
CH462826A (de) Verfahren zur Herstellung von Aminoacylcytosaminderivaten
CH489509A (de) Verfahren zur Herstellung von Derivaten des Piperazins
CH459215A (de) Verfahren zur Herstellung von Thiaminderivaten
CH473090A (de) Verfahren zur Herstellung von Anilin-Derivaten
CH484150A (de) Verfahren zur Herstellung von 2-substituierten Cycloheptimidazolderivaten
CH480317A (de) Verfahren zur Herstellung von 16-Methylen-19-nor-progesteron-derivaten
CH464219A (de) Verfahren zur Herstellung von Iminodibenzyl-Derivaten
CH484855A (de) Verfahren zur Herstellung von Acryloylphenolderivaten
CH449017A (de) Verfahren zur Herstellung von Derivaten des 3-Phenylpyrrols
CH456592A (de) Verfahren zur Herstellung von Piperidin-Derivaten
CH458393A (de) Verfahren zur Herstellung von homocyclischen Derivaten
CH458370A (de) Verfahren zur Herstellung von Imidazolidinonsulfonamidderivaten
CH461496A (de) Verfahren zur Herstellung von substituierten Piperidinderivaten